Comparison

ERK1/2 inhibitor 6 European Partner

Item no. HY-145028-100mg
Manufacturer MedChem Express
CASRN 2634816-13-8
Amount 100 mg
Quantity options 100 mg 1 ea
Category
Type Inhibitors
Specific against other
Citations [1]Jin Li, et al. Erk1/2 protein kinase inhibitors and their uses. Patent WO2021063335A1.
Smiles O=C1C2=CC(C3=NC(NC4CCOCC4)=NC=C3Cl)=CN2N=CN1[C@H](C)C(N[C@@H](C5=CC(OC)=CC(F)=C5)CO)=O
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Shipping Condition Room temperature
Available
Manufacturer - Type
Reference compound
Manufacturer - Applications
COVID-19-immunoregulation
Manufacturer - Targets
ERK
Shipping Temperature
Room temperature
Molecular Weight
586.01
Product Description
ERK1/2 inhibitor 6 is a potent inhibitor of ERK1/2. Mitogen-activated protein kinase (MAPK) plays an extremely important role in the signal transduction pathway, and extracellular signal regulated kinase (ERK) is a member of the MAPK family. ERK1/2 inhibitor 6 has the potential for the research or prevention of cancer, inflammation or other proliferative diseases (extracted from patent WO2021063335A1, compound 1)[1].
Manufacturer - Research Area
Cancer; Inflammation/Immunology
Solubility
10 mM in DMSO
Manufacturer - Pathway
MAPK/ERK Pathway; Stem Cell/Wnt
Clinical information
No Development Reported

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close